Episurf Medical AB (publ) (STO:EPIS.B)
Sweden · Delayed Price · Currency is SEK 0.0749
-0.0016 (-2.09%)
Sep 25, 2026, 3:05 PM CET
Episurf Medical AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -295.2 | -58.2 | -76 | -94.8 | -77.3 | -69.3 |
Depreciation & Amortization | 5.6 | 5.6 | 6 | 6 | 5.1 | 5.3 |
Other Amortization | 2.5 | 2.5 | 3 | 2.7 | 2.3 | 2.1 |
Stock-Based Compensation | 0.3 | 0.3 | 1 | 0.7 | -0.2 | 3.3 |
Other Operating Activities | 8.1 | 0.6 | - | -0.2 | -0.3 | -0.3 |
Change in Accounts Receivable | -2.8 | -2.8 | -0.8 | 0.4 | -0.3 | -1 |
Change in Inventory | 0.2 | 0.2 | 0.5 | -1.8 | 0.1 | - |
Change in Other Net Operating Assets | 71.6 | -3.5 | -5.1 | 2.2 | 1.1 | 0.2 |
Operating Cash Flow | -27.2 | -55.3 | -71.4 | -84.8 | -69.5 | -59.7 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -3.9 | - | - | - | - | -0.1 |
Sale (Purchase) of Intangibles | -6.7 | -6.7 | -7.6 | -9.5 | -11.3 | -6.9 |
Investment in Securities | - | - | - | - | - | 0.5 |
Other Investing Activities | 2.9 | - | - | - | 0.1 | - |
Investing Cash Flow | -7.7 | -6.7 | -7.6 | -9.5 | -11.2 | -6.5 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Lease Payments | -3.6 | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Net Debt Issued (Repaid) | -3.7 | -3.6 | -2.4 | -3.2 | -2.4 | -2.4 |
Issuance of Common Stock | 42.5 | 29.7 | 90.2 | 0.2 | 0.5 | 159.6 |
Other Financing Activities | -20 | -7.5 | -16.2 | - | - | -8 |
Financing Cash Flow | 18.8 | 18.6 | 71.6 | -3 | -1.9 | 149.2 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Miscellaneous Cash Flow Adjustments | -0.6 | - | - | -0.1 | - | - |
Net Cash Flow | -16.7 | -43.4 | -7.4 | -97.4 | -82.6 | 83 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -31.1 | -55.3 | -71.4 | -84.8 | -69.5 | -59.8 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -119.16% | -409.63% | -549.23% | -823.30% | -1053.03% | -920.00% |
Free Cash Flow Per Share | -0.01 | -0.06 | -0.15 | -0.27 | -0.26 | -0.26 |
Levered Free Cash Flow | 77.35 | -40.4 | -51.48 | -60.26 | -51.76 | -40.46 |
Unlevered Free Cash Flow | 86.91 | -40.03 | -50.85 | -59.7 | -51.33 | -40.34 |
Free Cash Flow After Leases | -34.7 | -58.9 | -73.8 | -88 | -71.9 | -62.2 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.3 | 0.3 | 1 | 0.6 | 0.6 | 0.2 |
Change in Working Capital | 69 | -6.1 | -5.4 | 0.8 | 0.9 | -0.8 |